{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T05:06:26Z","timestamp":1795151186537,"version":"4.10.3"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T00:00:00Z","timestamp":1775260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-026-03158-4","type":"journal-article","created":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T11:04:34Z","timestamp":1775300674000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The association between liver fat content and plasma metabolite profiles in fasting and postprandial states: an integration of a cohort study and a randomized controlled trial"],"prefix":"10.1186","volume":"25","author":[{"given":"Yan","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9e","family":"de Mutsert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anouk","family":"Gijbels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hildo","family":"Lamb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frits R.","family":"Rosendaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis O.","family":"Mook-Kanamori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ko Willems","family":"van Dijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia A.","family":"Afman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruifang","family":"Li-Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,4]]},"reference":[{"issue":"7","key":"3158_CR1","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1111\/liv.15575","volume":"43","author":"TO Faquih","year":"2023","unstructured":"Faquih TO, van Klinken JB, Li-Gao R, et al. Hepatic triglyceride content is intricately associated with numerous metabolites and biochemical pathways. Liver Int. 2023;43(7):1458\u201372.","journal-title":"Liver Int"},{"issue":"7","key":"3158_CR2","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/ijo.2012.181","volume":"37","author":"R Rametta","year":"2013","unstructured":"Rametta R, Mozzi E, Dongiovanni P, et al. Increased insulin receptor substrate 2 expression is associated with steatohepatitis and altered lipid metabolism in obese subjects. Int J Obes. 2013;37(7):986\u201392.","journal-title":"Int J Obes"},{"key":"3158_CR3","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1007\/s00125-005-1682-x","volume":"48","author":"E Bugianesi","year":"2005","unstructured":"Bugianesi E, Gastaldelli A, Vanni E, et al. Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia. 2005;48:634\u201342.","journal-title":"Diabetologia"},{"issue":"8","key":"3158_CR4","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.tem.2024.02.007","volume":"35","author":"L Miao","year":"2024","unstructured":"Miao L, Targher G, Byrne CD, Cao YY, Zheng MH. Current status and future trends of the global burden of MASLD. Trends Endocrin Met. 2024;35(8):697\u2013707.","journal-title":"Trends Endocrin Met"},{"key":"3158_CR5","doi-asserted-by":"publisher","first-page":"100638","DOI":"10.1016\/j.ajpc.2024.100638","volume":"17","author":"M Nguyen","year":"2024","unstructured":"Nguyen M, Asgharpour A, Dixon DL, Sanyal AJ, Mehta A. Emerging therapies for MASLD and their impact on plasma lipids. Am J Prev Cardiol. 2024;17:100638.","journal-title":"Am J Prev Cardiol"},{"issue":"1","key":"3158_CR6","doi-asserted-by":"publisher","first-page":"187","DOI":"10.5114\/ceh.2023.130744","volume":"9","author":"AE Platek","year":"2023","unstructured":"Platek AE, Szymanska A. Metabolic dysfunction-associated steatotic liver disease as a cardiovascular risk factor. Clin Experimental Hepatol. 2023;9(1):187\u201392.","journal-title":"Clin Experimental Hepatol"},{"issue":"3","key":"3158_CR7","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.metabol.2010.03.006","volume":"60","author":"SC Kalhan","year":"2011","unstructured":"Kalhan SC, Guo L, Edmison J, et al. Plasma metabolomic profile in nonalcoholic fatty liver disease. Metabolism. 2011;60(3):404\u201313.","journal-title":"Metabolism"},{"issue":"4","key":"3158_CR8","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1002\/hep.21763","volume":"46","author":"P Puri","year":"2007","unstructured":"Puri P, Baillie RA, Wiest MM, et al. A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology. 2007;46(4):1081\u201390.","journal-title":"Hepatology"},{"issue":"9","key":"3158_CR9","doi-asserted-by":"publisher","first-page":"4501","DOI":"10.1021\/pr1002593","volume":"9","author":"J Barr","year":"2010","unstructured":"Barr J, V\u00e1zquez-Chantada M, Alonso C, et al. Liquid Chromatography-Mass Spectrometry-Based Parallel Metabolic Profiling of Human and Mouse Model Serum Reveals Putative Biomarkers Associated with the Progression of Nonalcoholic Fatty Liver Disease. J Proteome Res. 2010;9(9):4501\u201312.","journal-title":"J Proteome Res"},{"issue":"6","key":"3158_CR10","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1002\/hep.23229","volume":"50","author":"P Puri","year":"2009","unstructured":"Puri P, Wiest MM, Cheung O, et al. The Plasma Lipidomic Signature of Nonalcoholic Steatohepatitis. Hepatology. 2009;50(6):1827\u201338.","journal-title":"Hepatology"},{"issue":"4","key":"3158_CR11","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1002\/oby.23687","volume":"31","author":"L Gnatiuc Friedrichs","year":"2023","unstructured":"Gnatiuc Friedrichs L, Trichia E, Aguilar-Ramirez D, Preiss D. Metabolic profiling of MRI-measured liver fat in the UK Biobank. Obes (Silver Spring). 2023;31(4):1121\u201332.","journal-title":"Obes (Silver Spring)"},{"issue":"10","key":"3158_CR12","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s11306-019-1599-x","volume":"15","author":"S Boone","year":"2019","unstructured":"Boone S, Mook-Kanamori D, Rosendaal F, et al. Metabolomics: a search for biomarkers of visceral fat and liver fat content. Metabolomics. 2019;15(10):139.","journal-title":"Metabolomics"},{"key":"3158_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101853","author":"EY Tan","year":"2024","unstructured":"Tan EY, Muthiah MD, Sanyal AJ. Metabolomics at the cutting edge of risk prediction of MASLD. Cell Rep Med. 2024. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101853","journal-title":"Cell Rep Med"},{"issue":"1","key":"3158_CR14","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/hep.29465","volume":"67","author":"M Gaggini","year":"2018","unstructured":"Gaggini M, Carli F, Rosso C, et al. Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance. Hepatology. 2018;67(1):145\u201358.","journal-title":"Hepatology"},{"key":"3158_CR15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/metabo14120725","volume":"14","author":"M Mischitelli","year":"2024","unstructured":"Mischitelli M, Poggiogalle E, Tozzi G, et al. Reduced Intra- and Extracellular Circulating Postprandial Lysosomal Acid Lipase Activity in Patients with MASLD. Metabolites. 2024;14:12.","journal-title":"Metabolites"},{"issue":"7","key":"3158_CR16","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1053\/j.gastro.2022.03.004","volume":"162","author":"TJ Velenosi","year":"2022","unstructured":"Velenosi TJ, Ben-Yakov G, Podszun MC, et al. Postprandial Plasma Lipidomics Reveal Specific Alteration of Hepatic-derived Diacylglycerols in Nonalcoholic Fatty Liver Disease. Gastroenterology. 2022;162(7):1990\u20132003.","journal-title":"Gastroenterology"},{"key":"3158_CR17","doi-asserted-by":"publisher","DOI":"10.12771\/emj.2024.e17","author":"SK Joo","year":"2024","unstructured":"Joo SK, Kim W. Sex differences in metabolic dysfunction-associated steatotic liver disease: a narrative review. Ewha Med J. 2024. https:\/\/doi.org\/10.12771\/emj.2024.e17","journal-title":"Ewha Med J"},{"issue":"5","key":"3158_CR18","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.3390\/jcm9051278","volume":"9","author":"A Lonardo","year":"2020","unstructured":"Lonardo A, Suzuki A. Sexual dimorphism of NAFLD in adults. Focus on clinical aspects and implications for practice and translational research. J Clin Med. 2020;9(5):1278.","journal-title":"J Clin Med"},{"key":"3158_CR19","doi-asserted-by":"publisher","first-page":"123057","DOI":"10.3389\/fendo.2023.1230457","volume":"14","author":"C Fotakis","year":"2023","unstructured":"Fotakis C, Kalafati IP, Amanatidou AI et al. Serum metabolomic profiling unveils distinct sex-related metabolic patterns in NAFLD. Front Endocrinol 2023;14:123057.","journal-title":"Front Endocrinol"},{"issue":"2","key":"3158_CR20","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.ogc.2009.03.001","volume":"36","author":"F Magkos","year":"2009","unstructured":"Magkos F, Mittendorfer B. Gender differences in lipid metabolism and the effect of obesity. Obstet Gyn Clin N Am. 2009;36(2):245.","journal-title":"Obstet Gyn Clin N Am"},{"issue":"4","key":"3158_CR21","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S0022-2275(20)38520-5","volume":"29","author":"JS Cohn","year":"1988","unstructured":"Cohn JS, Mcnamara JR, Cohn SD, Ordovas JM, Schaefer EJ. Postprandial plasma-lipoprotein changes in human-subjects of different ages. J Lipid Res. 1988;29(4):469\u201379.","journal-title":"J Lipid Res"},{"issue":"1","key":"3158_CR22","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1093\/ajcn\/nqac025","volume":"116","author":"S Schutte","year":"2022","unstructured":"Schutte S, Esser D, Siebelink E, et al. Diverging metabolic effects of 2 energy-restricted diets differing in nutrient quality: a 12-week randomized controlled trial in subjects with abdominal obesity. Am J Clin Nutr. 2022;116(1):132\u201350.","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"3158_CR23","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s10654-013-9801-3","volume":"28","author":"R de Mutsert","year":"2013","unstructured":"de Mutsert R, den Heijer M, Rabelink TJ, et al. The Netherlands Epidemiology of Obesity (NEO) study: study design and data collection. Eur J Epidemiol. 2013;28(6):513\u201323.","journal-title":"Eur J Epidemiol"},{"key":"3158_CR24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12263-017-0570-6","volume":"12","author":"S Wopereis","year":"2017","unstructured":"Wopereis S, Stroeve JHM, Stafleu A, et al. Multi-parameter comparison of a standardized mixed meal tolerance test in healthy and type 2 diabetic subjects: the PhenFlex challenge. Genes Nutr. 2017;12:21.","journal-title":"Genes Nutr"},{"issue":"2","key":"3158_CR25","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1148\/radiol.2015150035","volume":"279","author":"RL Widya","year":"2016","unstructured":"Widya RL, de Mutsert R, den Heijer M, et al. Association between Hepatic Triglyceride Content and Left Ventricular Diastolic Function in a Population-based Cohort: The Netherlands Epidemiology of Obesity Study. Radiology. 2016;279(2):443\u201350.","journal-title":"Radiology"},{"issue":"2","key":"3158_CR26","doi-asserted-by":"publisher","first-page":"E462","DOI":"10.1152\/ajpendo.00064.2004","volume":"288","author":"LS Szczepaniak","year":"2005","unstructured":"Szczepaniak LS, Nurenberg P, Leonard D, et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiology-Endocrinology Metabolism. 2005;288(2):E462\u20138.","journal-title":"Am J Physiology-Endocrinology Metabolism"},{"issue":"Oce4","key":"3158_CR27","doi-asserted-by":"publisher","first-page":"E384","DOI":"10.1017\/S0029665124006220","volume":"83","author":"SM Mullin","year":"2024","unstructured":"Mullin SM, Shannon CE, Ni Chathail MBN, Singh P, Norris S, Roche HM. Investigating the postprandial metabolic and inflammatory phenotypes of healthy subjects and patients with metabolic dysfunction-associated steatotic liver disease and metabolic-dysfunction associated steatohepatitis to understand disease progression. Proc Nutr Soc. 2024;83(Oce4): E384.","journal-title":"Proc Nutr Soc"},{"issue":"1","key":"3158_CR28","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1161\/CIRCGENETICS.114.000216","volume":"8","author":"P Soininen","year":"2015","unstructured":"Soininen P, Kangas AJ, W\u00fcrtz P, Suna T, Ala-Korpela M. Quantitative Serum Nuclear Magnetic Resonance Metabolomics in Cardiovascular Epidemiology and Genetics. Circ-Cardiovasc Gene. 2015;8(1):192\u2013206.","journal-title":"Circ-Cardiovasc Gene"},{"issue":"2","key":"3158_CR29","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2337\/diacare.18.2.245","volume":"18","author":"DB Allison","year":"1995","unstructured":"Allison DB, Paultre F, Maggio C, Mezzitis N, Pi-Sunyer FX. The use of areas under curves in diabetes research. Diabetes Care. 1995;18(2):245\u201350.","journal-title":"Diabetes Care"},{"issue":"5","key":"3158_CR30","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/sj.ejcn.1602581","volume":"61","author":"AC Verkleij-Hagoort","year":"2007","unstructured":"Verkleij-Hagoort AC, de Vries JHM, Stegers MPG, Lindemans J, Ursem NTC, Steegers-Theunissen RPM. Validation of the assessment of folate and vitamin B intake in women of reproductive age: the method of triads. Eur J Clin Nutr. 2007;61(5):610\u20135.","journal-title":"Eur J Clin Nutr"},{"issue":"1","key":"3158_CR31","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1475-2891-11-49","volume":"11","author":"L van Lee","year":"2012","unstructured":"van Lee L, Geelen A, van Huysduynen EJCH, de Vries JHM, van\u2019t Veer P, Feskens EJM. The Dutch Healthy Diet index (DHD-index): an instrument to measure adherence to the Dutch Guidelines for a Healthy Diet. Nutr J. 2012;11(1):49.","journal-title":"Nutr J"},{"issue":"2","key":"3158_CR32","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/s41366-019-0441-x","volume":"44","author":"E van Eekelen","year":"2020","unstructured":"van Eekelen E, Geelen A, Alssema M, et al. Adherence to dietary guidelines in relation to visceral fat and liver fat in middle-aged men and women: the NEO study. Int J Obes. 2020;44(2):297\u2013306.","journal-title":"Int J Obes"},{"issue":"1","key":"3158_CR33","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jclinepi.2011.05.005","volume":"65","author":"EL de Hollander","year":"2012","unstructured":"de Hollander EL, Zwart L, de Vries SI, Wendel-Vos W. The SQUASH was a more valid tool than the OBiN for categorizing adults according to the Dutch physical activity and the combined guideline. J Clin Epidemiol. 2012;65(1):73\u201381.","journal-title":"J Clin Epidemiol"},{"issue":"9","key":"3158_CR34","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.2105\/AJPH.81.9.1166","volume":"81","author":"EL Korn","year":"1991","unstructured":"Korn EL, Graubard BI. Epidemiologic Studies Utilizing Surveys - Accounting for the Sampling Design. Am J Public Health. 1991;81(9):1166\u201373.","journal-title":"Am J Public Health"},{"issue":"1","key":"3158_CR35","first-page":"1","volume":"9","author":"T Lumley","year":"2004","unstructured":"Lumley T. Analysis of complex survey samples. J Stat Softw. 2004;9(1):1\u201319.","journal-title":"J Stat Softw"},{"issue":"11","key":"3158_CR36","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1080\/13543784.2024.2401907","volume":"33","author":"K Dale","year":"2024","unstructured":"Dale K, Fallouh Y, Alkhouri N. MASLD and MASH: how a change of nomenclature may impact our approach in treating liver disease. Expert Opin Inv Drug. 2024;33(11):1095\u20137.","journal-title":"Expert Opin Inv Drug"},{"issue":"1","key":"3158_CR37","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the False Discovery Rate - a Practical and Powerful Approach to Multiple Testing. J R Stat Soc B. 1995;57(1):289\u2013300.","journal-title":"J R Stat Soc B"},{"issue":"2","key":"3158_CR38","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00038-013-0538-2","volume":"59","author":"D Vanderelst","year":"2014","unstructured":"Vanderelst D, Speybroeck N. Loading, merging and analysing demographic and health surveys using R. Int J Public Health. 2014;59(2):415\u201322.","journal-title":"Int J Public Health"},{"issue":"1","key":"3158_CR39","first-page":"52","volume":"2","author":"AR Kamel","year":"2023","unstructured":"Kamel AR, Abonazel MR. A simple introduction to regression modeling using R. Comput J Math Stat Sci. 2023;2(1):52\u201379.","journal-title":"Comput J Math Stat Sci"},{"issue":"3","key":"3158_CR40","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1194\/jlr.M200342-JLR200","volume":"44","author":"G Schonfeld","year":"2003","unstructured":"Schonfeld G, Patterson BW, Yablonskiy DA, et al. Fatty liver in familial hypobetalipoproteinemia: triglyceride assembly into VLDL particles is affected by the extent of hepatic steatosis. J Lipid Res. 2003;44(3):470\u20138.","journal-title":"J Lipid Res"},{"issue":"4","key":"3158_CR41","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00125-005-0125-z","volume":"49","author":"M Adiels","year":"2006","unstructured":"Adiels M, Taskinen MR, Packard C, et al. Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia. 2006;49(4):755\u201365.","journal-title":"Diabetologia"},{"issue":"2\u20133","key":"3158_CR42","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.cocis.2005.11.006","volume":"11","author":"JB German","year":"2006","unstructured":"German JB, Smilowitz JT, Zivkovic AM, Lipoproteins. When size really matters. Curr Opin Colloid In. 2006;11(2\u20133):171\u201383.","journal-title":"Curr Opin Colloid In"},{"issue":"29","key":"3158_CR43","doi-asserted-by":"publisher","first-page":"17106","DOI":"10.1074\/jbc.270.29.17106","volume":"270","author":"WS Davidson","year":"1995","unstructured":"Davidson WS, Rodrigueza WV, Lundkatz S, Johnson WJ, Rothblat GH, Phillips MC. Effects of Acceptor Particle-Size on the Efflux of Cellular Free-Cholesterol. J Biol Chem. 1995;270(29):17106\u201313.","journal-title":"J Biol Chem"},{"issue":"3","key":"3158_CR44","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1097\/RCT.0b013e3181cefb89","volume":"34","author":"MA Bredella","year":"2010","unstructured":"Bredella MA, Ghomi RH, Thomas BJ, et al. Breath-hold 1H-magnetic resonance spectroscopy for intrahepatic lipid quantification at 3 Tesla. J Comput Assist Tomogr. 2010;34(3):372\u20136.","journal-title":"J Comput Assist Tomogr"},{"issue":"5","key":"3158_CR45","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/j.1365-2796.2006.01643.x","volume":"259","author":"G Walldius","year":"2006","unstructured":"Walldius G, Jungner I. The apoB\/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid\u2010lowering therapy\u2013a review of the evidence. J Intern Med. 2006;259(5):493\u2013519.","journal-title":"J Intern Med"},{"key":"3158_CR46","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.2004.254","author":"G Walldius","year":"2004","unstructured":"Walldius G, Jungner I, Aastveit AH, Holme I, Furberg CD, Sniderman AD. The apoB\/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk. Clin Chem Lab Med. 2004. https:\/\/doi.org\/10.1515\/CCLM.2004.254","journal-title":"Clin Chem Lab Med"},{"issue":"9298","key":"3158_CR47","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1016\/S0140-6736(01)07098-2","volume":"358","author":"G Walldius","year":"2001","unstructured":"Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E. High apolipoprotein B, low apolipoprotein AI, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet. 2001;358(9298):2026\u201333.","journal-title":"Lancet"},{"issue":"1","key":"3158_CR48","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1038\/s41467-020-15684-0","volume":"11","author":"KHM Roumans","year":"2020","unstructured":"Roumans KHM, Lindeboom L, Veeraiah P, et al. Hepatic saturated fatty acid fraction is associated with de novo lipogenesis and hepatic insulin resistance. Nat Commun. 2020;11(1):1891.","journal-title":"Nat Commun"},{"issue":"1","key":"3158_CR49","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3945\/ajcn.114.092262","volume":"101","author":"JJ Lee","year":"2015","unstructured":"Lee JJ, Lambert JE, Hovhannisyan Y, et al. Palmitoleic acid is elevated in fatty liver disease and reflects hepatic lipogenesis. Am J Clin Nutr. 2015;101(1):34\u201343.","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"3158_CR50","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nm.2307","volume":"17","author":"TJ Wang","year":"2011","unstructured":"Wang TJ, Larson MG, Vasan RS, et al. Metabolite profiles and the risk of developing diabetes. Nat Med. 2011;17(4):448\u2013U483.","journal-title":"Nat Med"},{"issue":"6","key":"3158_CR51","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.cmet.2009.05.001","volume":"9","author":"CB Newgard","year":"2009","unstructured":"Newgard CB, An J, Bain JR, et al. A Branched-Chain Amino Acid-Related Metabolic Signature that Differentiates Obese and Lean Humans and Contributes to Insulin Resistance (9, pg 311, 2009). Cell Metab. 2009;9(6):565\u20136.","journal-title":"Cell Metab"},{"issue":"1","key":"3158_CR52","first-page":"220","volume":"102","author":"JT R\u00e4m\u00f6","year":"2017","unstructured":"R\u00e4m\u00f6 JT, Kaye SM, Jukarainen S, et al. Liver Fat and Insulin Sensitivity Define Metabolite Profiles During a Glucose Tolerance Test in Young Adult Twins. J Clin Endocr Metab. 2017;102(1):220\u201331.","journal-title":"J Clin Endocr Metab"},{"issue":"5","key":"3158_CR53","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.amjcard.2007.03.107","volume":"100","author":"JH O\u2019Keefe","year":"2007","unstructured":"O\u2019Keefe JH, Bell DS. Postprandial hyperglycemia\/hyperlipidemia (postprandial dysmetabolism) is a cardiovascular risk factor. Am J Cardiol. 2007;100(5):899\u2013904.","journal-title":"Am J Cardiol"},{"issue":"Suppl 1","key":"3158_CR54","doi-asserted-by":"publisher","first-page":"S53","DOI":"10.1016\/S0021-9150(98)00218-4","volume":"141","author":"N Mero","year":"1998","unstructured":"Mero N, Syvanne M, Taskinen MR. Postprandial lipid metabolism in diabetes. Atherosclerosis. 1998;141(Suppl 1):S53\u201355.","journal-title":"Atherosclerosis"},{"issue":"2","key":"3158_CR55","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1373\/clinchem.2009.133868","volume":"57","author":"SS Lund","year":"2011","unstructured":"Lund SS, Petersen M, Frandsen M, et al. Agreement between fasting and postprandial LDL cholesterol measured with 3 methods in patients with type 2 diabetes mellitus. Clin Chem. 2011;57(2):298\u2013308.","journal-title":"Clin Chem"},{"issue":"7","key":"3158_CR56","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1080\/00365510801995736","volume":"68","author":"S Lund","year":"2008","unstructured":"Lund S, Petersen M, Frandsen M, et al. Sustained postprandial decrease in plasma levels of LDL cholesterol in patients with type-2 diabetes mellitus. Scand J Clin Lab Investig. 2008;68(7):628\u201340.","journal-title":"Scand J Clin Lab Investig"},{"key":"3158_CR57","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.abb.2015.08.003","volume":"589","author":"DO Mook-Kanamori","year":"2016","unstructured":"Mook-Kanamori DO, de Mutsert R, Rensen PCN, et al. Type 2 diabetes is associated with postprandial amino acid measures. Arch Biochem Biophys. 2016;589:138\u201344.","journal-title":"Arch Biochem Biophys"},{"issue":"6","key":"3158_CR58","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s11883-003-0033-y","volume":"5","author":"D Hyson","year":"2003","unstructured":"Hyson D, Rutledge JC, Berglund L. Postprandial lipemia and cardiovascular disease. Curr Atheroscler Rep. 2003;5(6):437\u201344.","journal-title":"Curr Atheroscler Rep"},{"issue":"5","key":"3158_CR59","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1007\/s00125-015-3525-8","volume":"58","author":"B Verg\u00e8s","year":"2015","unstructured":"Verg\u00e8s B. Pathophysiology of diabetic dyslipidaemia: where are we? Diabetologia. 2015;58(5):886\u201399.","journal-title":"Diabetologia"},{"issue":"4","key":"3158_CR60","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/MOL.0b013e328304b63c","volume":"19","author":"AF Stalenhoef","year":"2008","unstructured":"Stalenhoef AF, de Graaf J. Association of fasting and nonfasting serum triglycerides with cardiovascular disease and the role of remnant-like lipoproteins and small dense LDL. Curr Opin Lipidol. 2008;19(4):355\u201361.","journal-title":"Curr Opin Lipidol"},{"issue":"7","key":"3158_CR61","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.numecd.2016.03.013","volume":"26","author":"S Haufe","year":"2016","unstructured":"Haufe S, Witt H, Engeli S, et al. Branched-chain and aromatic amino acids, insulin resistance and liver specific ectopic fat storage in overweight to obese subjects. Nutr Metab Cardiovas. 2016;26(7):637\u201342.","journal-title":"Nutr Metab Cardiovas"},{"issue":"1","key":"3158_CR62","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/s41467-023-36231-7","volume":"14","author":"H Julkunen","year":"2023","unstructured":"Julkunen H, Cichonska A, Tiainen M, et al. Atlas of plasma NMR biomarkers for health and disease in 118,461 individuals from the UK Biobank. Nat Commun. 2023;14(1):604.","journal-title":"Nat Commun"},{"key":"3158_CR63","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.molmet.2018.05.008","volume":"15","author":"BT Palmisano","year":"2018","unstructured":"Palmisano BT, Zhu L, Eckel RH, Stafford JM. Sex differences in lipid and lipoprotein metabolism. Mol Metab. 2018;15:45\u201355.","journal-title":"Mol Metab"},{"issue":"1","key":"3158_CR64","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12902-024-01663-9","volume":"24","author":"L Seidemann","year":"2024","unstructured":"Seidemann L, Lippold CP, Rohm CM, et al. Sex hormones differently regulate lipid metabolism genes in primary human hepatocytes. Bmc Endocr Disord. 2024;24(1):135.","journal-title":"Bmc Endocr Disord"},{"issue":"2","key":"3158_CR65","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1081\/JAS-51328","volume":"42","author":"ES Ford","year":"2005","unstructured":"Ford ES, Mannino DM. Time trends in obesity among adults with asthma in the United States: Findings from three national surveys. J Asthma. 2005;42(2):91\u20135.","journal-title":"J Asthma"},{"issue":"11","key":"3158_CR66","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1038\/s41591-019-0643-8","volume":"25","author":"E Gerdts","year":"2019","unstructured":"Gerdts E, Regitz-Zagrosek V. Sex differences in cardiometabolic disorders. Nat Med. 2019;25(11):1657\u201366.","journal-title":"Nat Med"},{"issue":"4","key":"3158_CR67","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1093\/jn\/135.4.681","volume":"135","author":"B Mittendorfer","year":"2005","unstructured":"Mittendorfer B. Sexual dimorphism in human lipid metabolism. J Nutr. 2005;135(4):681\u20136.","journal-title":"J Nutr"},{"issue":"9","key":"3158_CR68","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1161\/ATVBAHA.122.318247","volume":"43","author":"DM Conlon","year":"2023","unstructured":"Conlon DM, Welty FK, Reyes-Soffer G, Amengual J. Sex-Specific Differences in Lipoprotein Production and Clearance. Arterioscl Throm Vas. 2023;43(9):1617\u201325.","journal-title":"Arterioscl Throm Vas"},{"issue":"1","key":"3158_CR69","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12933-024-02188-0","volume":"23","author":"A Gijbels","year":"2024","unstructured":"Gijbels A, Erdos B, Trouwborst I, et al. Hepatic insulin resistance and muscle insulin resistance are characterized by distinct postprandial plasma metabolite profiles: a cross-sectional study. Cardiovasc Diabetol. 2024;23(1):97.","journal-title":"Cardiovasc Diabetol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-026-03158-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03158-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03158-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T13:02:56Z","timestamp":1775739776000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12933-026-03158-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,4]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3158"],"URL":"https:\/\/doi.org\/10.1186\/s12933-026-03158-4","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,4]]},"assertion":[{"value":"13 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The main study protocol was approved by the medical ethics committee of Leiden University Medical Center (NL21981.058.08\/P08.109) and the ethics committee of Wageningen University and Research (NCT02194504). All participants gave written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"119"}}